Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lateral Canthal Lines, LCL”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Testing effectiveness (Phase 2)Study completedNCT03912805
What this trial is testing

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Who this might be right for
Lateral Canthal Lines, LCLCrow's Feet
Eirion Therapeutics Inc. 38
Testing effectiveness (Phase 2)Study completedNCT04259086
What this trial is testing

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines

Who this might be right for
Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)
Revance Therapeutics, Inc. 48
Large-scale testing (Phase 3)Study completedNCT04157686
What this trial is testing

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Who this might be right for
Glabellar LinesLateral Canthal Lines
Medy-Tox 957
Large-scale testing (Phase 3)Study completedNCT04247074
What this trial is testing

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Who this might be right for
Glabellar Frown Lines (GL)Lateral Canthal Lines (LCL)
Galderma R&D 413
Testing effectiveness (Phase 2)Study completedNCT03911102
What this trial is testing

Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines

Who this might be right for
Lateral Canthal Lines
Revance Therapeutics, Inc. 63
Large-scale testing (Phase 3)Study completedNCT03721016
What this trial is testing

MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)

Who this might be right for
Glabellar LinesLateral Canthal Lines
Medy-Tox 415
Testing effectiveness (Phase 2)Study completedNCT04985916
What this trial is testing

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Who this might be right for
Lateral Canthal Lines, LCLCrow's Feet
Eirion Therapeutics Inc. 280
Post-approval studies (Phase 4)Not Yet RecruitingNCT07388927
What this trial is testing

A Real-World Study on Effect of Hirudoid on Ecchymosis After Treatment of Crow's Feet With Botulinum Toxin Type A

Who this might be right for
Ecchymosis After Periorbital Rejuvenation With Botulinum Toxin Type ACrow's Feet LinesLateral Canthal Lines, LCL
DKSH Management (Thailand) Limited 48